Skip to main content

Playkit May Aid Children in Preparing for MRI

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 8, 2023.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Nov. 8, 2023 -- A mixed reality playkit may help children prepare for magnetic resonance imaging (MRI) and reduce the need for anesthesia, according to a study published online Nov. 7 in BMJ Innovations.

Jill Thompson, from the University of Sheffield in the United Kingdom, and colleagues describe the development of a playkit that uses augmented/virtual reality combined with physical play to reduce the incidence of general anesthesia for children (ages 4 to 10 years) undergoing MRI, as well as some early acceptability testing with children.

The researchers reported that the kit allows for familiarization with the MRI scanner, opportunities to practice staying still, preparation for high noise levels, and simulation of the entire MRI process through a series of interactive games, which reduce anxiety levels for patients and their parents/caregivers. Interview data revealed that the playkit helped some children (and their parents/caregivers) to prepare to undertake an MRI and also helped to relieve anxiety during the scan.

"Following the positive qualitative results of this local project, we suggest a clinical trial across anesthetic departments nationally and internationally, and we encourage the uptake and rollout of the MRI playkit on a wider scale," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...

Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million

TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...

Patient–Primary Care Provider Language Concordance Tied to Better Outcomes

TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.